☆ 4.5 Article

Visually Identified Tau 18F-MK6240 PET Patterns in Symptomatic Alzheimer's Disease

JOURNAL OF ALZHEIMERS DISEASE (2022)

Related references

Note: Only part of the references are listed.

Article Radiology, Nuclear Medicine & Medical Imaging

Direct Comparison of the Tau PET Tracers 18F-Flortaucipir and 18F-MK-6240 in Human Subjects

Alexandra Gogola et al.

Summary: This study compared the characteristics of two frequently used tau PET tracers, F-18-flortaucipir and F-18-MK-6240, in the same subjects. The results showed that both tracers performed equally well in visual interpretations and were capable of quantifying signal in a common set of brain regions that develop tau pathology in Alzheimer disease. However, they also showed distinct patterns of apparent off-target binding, and F-18-MK-6240 exhibited a greater dynamic range in SUVR estimates.

JOURNAL OF NUCLEAR MEDICINE (2022)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Relationship between amyloid and tau levels and its impact on tau spreading

Vincent Dore et al.

Summary: The study found that Aβ levels between 10 and 40 CL are associated with spreading of tau protein in different brain regions, and abnormal levels of tau protein in the neocortex require Aβ levels above 40 CL. The highest prevalence of abnormal tau protein was found in the entorhinal cortex.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Add to Collection

Article Clinical Neurology

Association of APOE4 and Clinical Variability in Alzheimer Disease With the Pattern of Tau- and Amyloid-PET

Renaud La Joie et al.

Summary: Different clinical phenotypes in AD are associated with distinct patterns of tau but not amyloid pathology. Older age and APOE4 are risk factors for AD that also influence disease expression by promoting a more medial temporal lobe-predominant pattern of tau pathology.

NEUROLOGY (2021)

Add to Collection

Review Chemistry, Medicinal

Tauvid (TM): The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer's Disease

Caitlin V. M. L. Jie et al.

Summary: Tauvid, approved by the FDA in 2020 for PET imaging in AD patients, is a significant advancement in the field of AD research. This review summarizes the production, quality control, clinical application, pharmacology, and limitations of Tauvid, while also providing an overview of second-generation tau PET tracers.

PHARMACEUTICALS (2021)

Add to Collection

Article Neurosciences

Fifteen Years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study: Progress and Observations from 2,359 Older Adults Spanning the Spectrum from Cognitive Normality to Alzheimer's Disease

Christopher Fowler et al.

Summary: The AIBL study, which started in 2006, includes both Inception and Enrichment cohorts totaling over 8,500 person-years of investigation. It has contributed significantly to the understanding of Alzheimer's disease, providing valuable data for the development of interventions to delay, prevent, or treat the disease.

JOURNAL OF ALZHEIMERS DISEASE REPORTS (2021)

Add to Collection

Article Clinical Neurology

Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer's disease

Rik Ossenkoppele et al.

ALZHEIMERS & DEMENTIA (2020)

Add to Collection

Article Clinical Neurology

Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer's disease

Sanka Amadoru et al.

ALZHEIMERS RESEARCH & THERAPY (2020)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

In Vivo Characterization and Quantification of Neurofibrillary Tau PET Radioligand F-18-MK-6240 in Humans from Alzheimer Disease Dementia to Young Controls

Tobey J. Betthauser et al.

JOURNAL OF NUCLEAR MEDICINE (2019)

Add to Collection

Article Neurosciences

Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue

Cinthya Aguero et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)

Add to Collection

Article Neurosciences

Tau Subtypes of Alzheimer's Disease Determined in vivo Using Flortaucipir PET Imaging

Arnaud Charil et al.

JOURNAL OF ALZHEIMERS DISEASE (2019)

Add to Collection

Article Neurosciences

Implementing the centiloid transformation for 11C-PiB and β-amyloid 18F-PET tracers using CapAIBL

Pierrick Bourgeat et al.

NEUROIMAGE (2018)

Add to Collection

Article Neurosciences

The association between tau PET and retrospective cortical thinning in clinically normal elderly

Molly R. LaPoint et al.

NEUROIMAGE (2017)

Add to Collection

Article Clinical Neurology

Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline

Shannon L. Risacher et al.

NEUROLOGY (2017)

Add to Collection

Article Clinical Neurology

Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease

Chenjie Xia et al.

JAMA NEUROLOGY (2017)

Add to Collection

Article Clinical Neurology

Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease

Rik Ossenkoppele et al.

BRAIN (2016)

Add to Collection

Article Clinical Neurology

Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study

Samantha C. Burnham et al.

LANCET NEUROLOGY (2016)

Add to Collection

Article Neurosciences

PET Imaging of Tau Deposition in the Aging Human Brain

Michael Schoell et al.

NEURON (2016)

Add to Collection

Article Geriatrics & Gerontology

Comparison of MR-less PiB SUVR quantification methods

Pierrick Bourgeat et al.

NEUROBIOLOGY OF AGING (2015)

Add to Collection

Letter Clinical Neurology

Neuropathological subtypes of Alzheimer's disease

Kurt A. Jellinger

ACTA NEUROPATHOLOGICA (2012)

Add to Collection

Article Clinical Neurology

Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study

Melissa E. Murray et al.

LANCET NEUROLOGY (2011)

Add to Collection

Article Psychology, Clinical

The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease

Kathryn A. Ellis et al.

INTERNATIONAL PSYCHOGERIATRICS (2009)

Add to Collection

© Peeref 2019-2024. All rights reserved.